1 - 25 of 50 results for author:"Kimoto M." in Literature citations
Results Customize
› Repeat search in UniProtKB (1,105)
| Reduced surface expression of TLR4 by a V254I point mutation accounts for the low lipopolysaccharide responder phenotype of BALB/c B cells. Tsukamoto H., Fukudome K., Takao S., Tsuneyoshi N., Ohta S., Nagai Y., Ihara H., Miyake K., Ikeda Y., Kimoto M. J. Immunol. 190:195-204(2013) · Mapped (13) |
| Role of hepatocyte growth factor in promoting the growth of human corneal endothelial cells stimulated by L-ascorbic acid 2-phosphate. Kimoto M., Shima N., Yamaguchi M., Amano S., Yamagami S. Invest. Ophthalmol. Vis. Sci. 53:7583-7589(2012) · Mapped (5) |
| Protein N-myristoylation is required for cellular morphological changes induced by two formin family proteins, FMNL2 and FMNL3. Moriya K., Yamamoto T., Takamitsu E., Matsunaga Y., Kimoto M., Fukushige D., Kimoto C., Suzuki T., Utsumi T. Biosci. Biotechnol. Biochem. 76:1201-1209(2012) · Mapped (4) |
| Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation. Eguchi K., Manabe I., Oishi-Tanaka Y., Ohsugi M., Kono N., Ogata F., Yagi N., Ohto U., Kimoto M., Miyake K. et al. Cell Metab. 15:518-533(2012) · Mapped (22) |
| The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells. Nagai Y., Yanagibashi T., Watanabe Y., Ikutani M., Kariyone A., Ohta S., Hirai Y., Kimoto M., Miyake K., Takatsu K. Int. Immunol. 24:389-400(2012) · Mapped (14) |
| Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. Tsukamoto H., Fukudome K., Takao S., Tsuneyoshi N., Kimoto M. Int. Immunol. 22:271-280(2010) · Mapped (13) |
| Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Rodionov R.N., Dayoub H., Lynch C.M., Wilson K.M., Stevens J.W., Murry D.J., Kimoto M., Arning E., Bottiglieri T., Cooke J.P. et al. Circ. Res. 106:551-558(2010) · Mapped (5) |
| Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine. Hu X., Xu X., Zhu G., Atzler D., Kimoto M., Chen J., Schwedhelm E., Luneburg N., Boger R.H., Zhang P. et al. Circulation 120:2222-2229(2009) · Mapped (3) |
| Tumor-suppressive lipoxygenases inhibit the expression of c-myc mRNA coding region determinant-binding protein/insulin-like growth factor II mRNA-binding protein 1 in human prostate carcinoma PC-3 cells. Kawakami Y., Kubota N., Ekuni N., Suzuki-Yamamoto T., Kimoto M., Yamashita H., Tsuji H., Yoshimoto T., Jisaka M., Tanaka J. et al. Biosci. Biotechnol. Biochem. 73:1811-1817(2009) · Mapped (8) |
| Isolation and molecular cloning of a major wheat allergen, Tri a Bd 27K. Kimoto M., Suzuki M., Komiyama N., Kunimoto A., Yamashita H., Hiemori M., Takahashi K., Tsuji H. Biosci. Biotechnol. Biochem. 73:85-92(2009) · UniProtKB (1) |
| Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia. Dayal S., Rodionov R.N., Arning E., Bottiglieri T., Kimoto M., Murry D.J., Cooke J.P., Faraci F.M., Lentz S.R. Am. J. Physiol. Heart Circ. Physiol. 295:H816-25(2008) · Mapped (10) |
| Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Hasegawa K., Wakino S., Tatematsu S., Yoshioka K., Homma K., Sugano N., Kimoto M., Hayashi K., Itoh H. Circ. Res. 101:e2-10(2007) · Mapped (3) |
| Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomerization of TLR4 required for signal transduction. Tsuneyoshi N., Kohara J., Bahrun U., Saitoh S., Akashi S., Gauchat J.F., Kimoto M., Fukudome K. Cell. Immunol. 244:57-64(2006) · Mapped (7) |
| Effect of a hypolipidemic drug, Di (2-ethylhexyl) phthalate, on mRNA-expression associated fatty acid and acetate metabolism in rat tissues. Itsuki-Yoneda A., Kimoto M., Tsuji H., Hiemori M., Yamashita H. Biosci. Biotechnol. Biochem. 71:414-420(2007) · Mapped (1) |
| Contribution of whole blood to the control of plasma asymmetrical dimethylarginine. Billecke S.S., Kitzmiller L.A., Northrup J.J., Whitesall S.E., Kimoto M., Hinz A.V., D'Alecy L.G. Am. J. Physiol. 291:H1788-H1796(2006) · UniProtKB (1) |
| Acetate generation in rat liver mitochondria; acetyl-CoA hydrolase activity is demonstrated by 3-ketoacyl-CoA thiolase. Yamashita H., Itsuki A., Kimoto M., Hiemori M., Tsuji H. Biochim. Biophys. Acta 1761:17-23(2006) · Mapped (3) |
| Interaction analysis between tmRNA and SmpB from Thermus thermophilus. Nameki N., Someya T., Okano S., Suemasa R., Kimoto M., Hanawa-Suetsugu K., Terada T., Shirouzu M., Hirao I., Takaku H. et al. J. Biochem. 138:729-739(2005) · Mapped (1) |
| Comparison of lipopolysaccharide-binding functions of CD14 and MD-2. Koraha J., Tsuneyoshi N., Kimoto M., Gauchat J.F., Nakatake H., Fukudome K. Clin. Diagn. Lab. Immunol. 12:1292-1297(2005) · Mapped (4) |
| Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Jacobi J., Sydow K., von Degenfeld G., Zhang Y., Dayoub H., Wang B., Patterson A.J., Kimoto M., Blau H.M., Cooke J.P. Circulation 111:1431-1438(2005) · Mapped (5) |
| Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling. Ohta S., Bahrun U., Tanaka M., Kimoto M. Biochem. Biophys. Res. Commun. 323:1103-1108(2004) · Mapped (3) |
| Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Dayoub H., Achan V., Adimoolam S., Jacobi J., Stuehlinger M.C., Wang B.Y., Tsao P.S., Kimoto M., Vallance P., Patterson A.J. et al. Circulation 108:3042-3047(2003) · Mapped (3) |
| Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., Miyake K. Nat. Immunol. 3:667-672(2002) · Mapped (3) |
| Adaptor protein Shc is an isoform-specific direct activator of the tyrosine kinase c-Src. Sato K., Nagao T., Kakumoto M., Kimoto M., Otsuki T., Iwasaki T., Tokmakov A.A., Owada K., Fukami Y. J. Biol. Chem. 277:29568-29576(2002) · Mapped (7) |
| Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Nagai Y., Shimazu R., Ogata H., Akashi S., Sudo K., Yamasaki H., Hayashi S., Iwakura Y., Kimoto M., Miyake K. Blood 99:1699-1705(2002) · Mapped (1) |
| An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells. Kang E.S., Cates T.B., Harper D.N., Chiang T.M., Myers L.K., Acchiardo S.R., Kimoto M. Free Radic. Res. 35:693-707(2001) · Mapped (5) |